Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility
- PMID: 9931415
- DOI: 10.1016/s0005-2760(98)00177-5
Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility
Abstract
Platelet-activating factor acetylhydrolase (PAF-AH) is transported by lipoproteins in plasma and is thought to possess both anti-inflammatory and anti-oxidative activity. It has been reported that PAF-AH is recovered primarily in small, dense LDL and HDL following ultracentrifugal separation of lipoproteins. In the present studies, we aimed to further define the distribution of PAF-AH among lipoprotein fractions and subfractions, and to determine whether these distributions are affected by the lipoprotein isolation strategy (FPLC versus sequential ultracentrifugation) and LDL particle distribution profile. When lipoproteins were isolated by FPLC, the bulk (approximately 85%) of plasma PAF-AH activity was recovered within LDL-containing fractions, whereas with ultracentrifugation, there was a redistribution to HDL (which contained approximately 18% of the activity) and the d>1.21 g/ml fraction (which contained approximately 32%). Notably, re-ultracentrifugation of isolated LDL did not result in any further movement of PAF-AH to higher densities, suggesting the presence of dissociable and nondissociable forms of the enzyme on LDL. Differences were noted in the distribution of PAF-AH activity among LDL subfractions from subjects exhibiting the pattern A (primarily large, buoyant LDL) versus pattern B (primarily small, dense LDL) phenotype. In the latter group, there was a relative depletion of PAF-AH activity in subfractions in the intermediate to dense range (d=1.039-1.047 g/ml) with a corresponding increase in enzyme activity recovered within the d>1.21 g/ml ultracentrifugal fraction. Thus, there appears to be a greater proportion of the dissociable form of PAF-AH in pattern B subjects. In both populations, most of the nondissociable activity was recovered in a minor small, dense LDL subfraction. Based on conjugated dienes as a measure of lipid peroxidation, variations in PAF-AH activity appeared to contribute to variations in oxidative behavior among ultracentrifugally isolated LDL subfractions. The physiologic relevance of PAF-AH dissociability and the minor PAF-AH-enriched oxidation-resistant LDL subpopulation remains to be determined.
Similar articles
-
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.Eur J Clin Invest. 1997 Jul;27(7):595-602. doi: 10.1046/j.1365-2362.1997.1570706.x. Eur J Clin Invest. 1997. PMID: 9263748
-
PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.Atherosclerosis. 1996 Aug 23;125(1):121-34. doi: 10.1016/0021-9150(96)05872-8. Atherosclerosis. 1996. PMID: 8831934
-
PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.Arterioscler Thromb Vasc Biol. 1995 Oct;15(10):1764-73. doi: 10.1161/01.atv.15.10.1764. Arterioscler Thromb Vasc Biol. 1995. PMID: 7583554
-
Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis.Biochem Pharmacol. 2003 Dec 1;66(11):2069-73. doi: 10.1016/s0006-2952(03)00559-8. Biochem Pharmacol. 2003. PMID: 14609731 Review.
-
Plasma PAF-acetylhydrolase: an unfulfilled promise?Biochim Biophys Acta. 2006 Nov;1761(11):1351-8. doi: 10.1016/j.bbalip.2006.05.008. Epub 2006 May 23. Biochim Biophys Acta. 2006. PMID: 16807087 Review.
Cited by
-
Uremia alters HDL composition and function.J Am Soc Nephrol. 2011 Sep;22(9):1631-41. doi: 10.1681/ASN.2010111144. Epub 2011 Jul 29. J Am Soc Nephrol. 2011. PMID: 21804091 Free PMC article.
-
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications.World J Cardiol. 2015 Oct 26;7(10):609-20. doi: 10.4330/wjc.v7.i10.609. World J Cardiol. 2015. PMID: 26516415 Free PMC article. Review.
-
Unraveling the PAF-AH/Lp-PLA2 controversy.J Lipid Res. 2014 Sep;55(9):1811-4. doi: 10.1194/jlr.E052886. Epub 2014 Jul 9. J Lipid Res. 2014. PMID: 25007789 Free PMC article. No abstract available.
-
Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia.J Lipid Res. 2012 Aug;53(8):1670-8. doi: 10.1194/jlr.P027235. Epub 2012 May 24. J Lipid Res. 2012. PMID: 22628616 Free PMC article.
-
Fetal High-Density Lipoproteins: Current Knowledge on Particle Metabolism, Composition and Function in Health and Disease.Biomedicines. 2021 Mar 30;9(4):349. doi: 10.3390/biomedicines9040349. Biomedicines. 2021. PMID: 33808220 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous